NCT02139072View on ClinicalTrials.gov

CoaguChek XS in Antiphospholipid Antibody Syndrome (APL) Patients

CompletedOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

January 31, 2016

Study Completion Date

January 31, 2016

Conditions
Antiphospholipid Antibody Syndrome
Interventions
DEVICE

CoaguChek XS

CoaguChek XS will be used to measure INR in patients with APL

PROCEDURE

Standard Lab Draw

Patients on warfarin for any indication other than APL will measure INR by venous lab draw

Trial Locations (1)

32610

UF and Shands Health, Gainesville

All Listed Sponsors
collaborator

Hoffmann-La Roche

INDUSTRY

lead

University of Florida

OTHER

NCT02139072 - CoaguChek XS in Antiphospholipid Antibody Syndrome (APL) Patients | Biotech Hunter | Biotech Hunter